Myeloma Minute: Brave New World of Gene Editing

Brave New World of Gene Editing, Part One

In the first of a two-part series, IMF Chairman Dr. Brian Durie examines the exciting gene-editing technology known as CRISPR and its impact on the future of medicine. From drinkable solutions to skin grafts, Dr. Durie says the possible uses of CRISPR technology “may seem like science fiction.” Read Dr. Durie’s blog.

Save the Date: The IMF's 11th Annual Comedy Celebration - Saturday, November 4, 2017

The IMF’s 11th Annual Comedy Celebration will be held on Saturday, November 4, 2017, in Los Angeles. Ray Romano will host a cast of stellar comedians and performers in raising funds for the Peter Boyle Research Fund supporting the IMF’s groundbreaking Black Swan Research Initiative®. This year, we are excited to announce that members from around the world will be able to participate remotely, as the evening’s silent auction takes place ONLINE simultaneously! Learn more at

Watch a Replay of the 'Living Well with Myeloma: Making Sense of Tests and Results' Webinar​

Watch a replay of this “Living Well with Myeloma” webinar on Making Sense of Tests and Results. IMF Medical Editor Debbie Birns outlines the various tests used to diagnose myeloma, monitor response to treatment, and detect side effects. 

Who Says There Is No Such Thing as a Free Lunch?

Last Friday, the SoCal Honda Dealers stopped by the home office of the International Myeloma Foundation in North Hollywood, California, to deliver a Random Act of Helpfulness. “We are giving back one day out of this month to those who are helpful every day of the year,” said Tami of SoCal Honda’s Team Aqua. While the IMF staff was grateful for the delicious pizza, brownies, and garlic bread, they were especially grateful to Holly Carson, the IMF member who nominated our organization for this midday feast!​

IMF and University of Heidelberg Host a Successful Patient & Family Seminar

The IMF Patient & Family Seminar in Heidelberg was held on September 24, 2017. With more than 200 participants, the event was a great success. Dr. Hartmut Goldschmidt and his team at the University of Heidelberg hosted the meeting, which was greatly appreciated by the German myeloma community. Guest speaker Dr. Rafat Abonour (Indiana University-Simon Cancer Center) presented “Advances in the Therapy of Multiple Myeloma” and received a standing ovation.

What do you recommend if a patient experiences fatigue on the combination of Revlimid, Darzalex, and dexamethasone?

In this week’s video, Dr. Brian GM Durie suggests ways to manage side effects if you are on a triplet combination.


This weekly newsletter is supported from funds by donors like you. Donate to continue to make publications like this one possible.

We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Pharmaceuticals, and Takeda Oncology



Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.